Insights

Nondriver NSCLC Trials: KEYNOTE-189, -407, -024
April 17, 2019 – 
A discussion on the design, results, and practical implication of KEYNOTE-189, -407, and -024 trials.
 
Nondriver NSCLC Treatment Factors
April 17, 2019 – 
Expert physicians discuss the factors considered when choosing treatment for nondriver non–small cell lung cancer.
Multiple Sclerosis: Considering Symptoms and Diagnosis
April 15, 2019 – 
A comprehensive outline of symptoms tied to multiple sclerosis, as well as the proper pathway for diagnosis.
The Nature of Multiple Sclerosis
April 15, 2019 – 
Key opinion leaders elucidate the complex nature of multiple sclerosis and heterogeneity within the disease.
 
AxSpa Treatment Goals and Windows of Opportunity
March 28, 2019 – 
Hillary Norton, MD, considers the windows of opportunity in managing axial spondyloarthritis to prevent various comorbidities and discusses the goals of therapy.
 
Diagnosing Axial Spondyloarthritis
March 28, 2019 – 
Hillary Norton, MD, discusses the diagnosis of axial spondyloarthritis, namely the difficulties of accurate and timely identification, and considers possible comorbidities.
 
Advice for NrAxSpa Patients & Future of Treatment
March 21, 2019 – 
Tiffany Westrich-Robertson provides advice for people with nonradiographical axial spondyloarthritis, and considers the future of autoimmune and autoinflammatory treatment.

 
The Epidemiology of Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, discusses the epidemiology of axial spondyloarthritis.
Nonradiographic Versus Radiographic Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, considers the differences between nonradiographic and radiographic axial spondyloarthritis and discusses the impact of these diseases on everyday life.
Next-Generation Sequencing in Patients With NSCLC
March 15, 2019 – 
Key opinion leaders discuss the role of next-generation sequencing (NGS) in determining the appropriate treatment for patients with non–small cell lung cancer.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.